New Ways to Quit Smoking - MSN Health & Fitness
From China comes the Ruyan E-Cigarette, an electronic nicotine inhaler designed to mimic the smoking experience, complete with exhaled vapor. Nicotine vaporizing cartridges are snapped into the device, and are available in four different nicotine doses, from 0 mg to 16 mg. Ruyan also sells e-pipes and e-cigars.
Do these products work, or are they gimmicks?
Thomas Glynn, American Cancer Society director of cancer science and trends, says people are very curious about high-tech devices, but he’s concerned that there is no data yet to back up their use.
“I don’t see anything in [these newer approaches] that I’d say is a magic bullet,” he says. “Unfortunately, one real challenge we have in helping people to stop is getting them to accept that quitting is hard work.”
There’s also a risk, Glynn says, that people will try high-tech methods and, if they don’t work, “might throw their hands up and say, ‘I can’t stop.’ And we’ll lose an opportunity for someone who can quit.”
Glen Morgan, a clinical psychologist and program director at the tobacco Control Research Branch of the National Cancer Institute, concurs.
“If I’m not familiar with a product or heard of studies supporting its use, I wouldn’t recommend it to anybody any more than, say, chewing peach pits if you have cancer,” he says.
From China comes the Ruyan E-Cigarette, an electronic nicotine inhaler designed to mimic the smoking experience, complete with exhaled vapor. Nicotine vaporizing cartridges are snapped into the device, and are available in four different nicotine doses, from 0 mg to 16 mg. Ruyan also sells e-pipes and e-cigars.
Do these products work, or are they gimmicks?
Thomas Glynn, American Cancer Society director of cancer science and trends, says people are very curious about high-tech devices, but he’s concerned that there is no data yet to back up their use.
“I don’t see anything in [these newer approaches] that I’d say is a magic bullet,” he says. “Unfortunately, one real challenge we have in helping people to stop is getting them to accept that quitting is hard work.”
There’s also a risk, Glynn says, that people will try high-tech methods and, if they don’t work, “might throw their hands up and say, ‘I can’t stop.’ And we’ll lose an opportunity for someone who can quit.”
Glen Morgan, a clinical psychologist and program director at the tobacco Control Research Branch of the National Cancer Institute, concurs.
“If I’m not familiar with a product or heard of studies supporting its use, I wouldn’t recommend it to anybody any more than, say, chewing peach pits if you have cancer,” he says.
